Evaluation of the Expression EGFR, HER2/NEU and the End Effector ERK of the RAS/RAF/MAP Kinase Pathway in Prostatic Adenocarcinoma for a Possible Role as New Target Therapy.
Autor: | Shalaby, Asem, Mahmoud, Heba A., Sayed, Shaymaa G., Al Hashmi, Khalid, Al Sinawi, Shadia, Al Badi, Suaad, Al Rashdi, Afrah, Al Husaini, Samya, Al Badi, Hajer, Saad El-Din, Somaia Ahmed |
---|---|
Zdroj: | Asian Pacific Journal of Cancer Prevention; Jun2024, Vol. 25 Issue 6, p2193-2201, 9p |
Databáze: | Complementary Index |
Externí odkaz: |